BERGAGGIO, ELISA
 Distribuzione geografica
Continente #
EU - Europa 333
NA - Nord America 333
AS - Asia 112
AF - Africa 4
OC - Oceania 2
SA - Sud America 2
Totale 786
Nazione #
US - Stati Uniti d'America 329
IT - Italia 240
CN - Cina 60
SG - Singapore 26
SE - Svezia 18
IE - Irlanda 15
UA - Ucraina 13
DE - Germania 8
GB - Regno Unito 7
AT - Austria 6
FR - Francia 6
JP - Giappone 6
CA - Canada 4
FI - Finlandia 4
KR - Corea 4
BE - Belgio 3
ID - Indonesia 3
IN - India 3
RO - Romania 3
SN - Senegal 3
VN - Vietnam 3
CH - Svizzera 2
ES - Italia 2
HK - Hong Kong 2
PL - Polonia 2
AU - Australia 1
BR - Brasile 1
BY - Bielorussia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
HR - Croazia 1
IR - Iran 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 786
Città #
Torino 87
Turin 58
Chandler 47
Fairfield 25
Novara 25
Beijing 22
Singapore 21
Ashburn 19
Cambridge 19
Woodbridge 18
Dublin 15
Wilmington 13
Houston 12
Jacksonville 10
New York 10
Bologna 9
Nyköping 9
Seattle 9
Fremont 7
Columbus 6
Guangzhou 6
Vienna 6
Ann Arbor 5
Jinan 5
Medford 5
Santa Clara 5
Latina 4
Ottawa 4
Pisa 4
Princeton 4
Rome 4
Boardman 3
Boston 3
Brussels 3
Dearborn 3
Dong Ket 3
Durham 3
Heidelberg 3
Jakarta 3
Nanjing 3
Redwood City 3
San Diego 3
San Francisco 3
San Mateo 3
Suzhou 3
Cadoneghe 2
Flushing 2
Galati 2
Geneve 2
Lecce 2
London 2
Serravalle Scrivia 2
Shanghai 2
Upper Marlboro 2
Villeurbanne 2
Warsaw 2
Xian 2
Yuba City 2
Zhengzhou 2
Ankara 1
Ascoli Piceno 1
Auckland 1
Berlin 1
Braintree 1
Canberra 1
Caselle Torinese 1
Central District 1
Centrale 1
Centreville 1
Chongqing 1
Clarks Summit 1
Düsseldorf 1
Edinburgh 1
Grugliasco 1
Guiyang 1
Hangzhou 1
Hefei 1
Helsinki 1
Los Angeles 1
Madrid 1
Medellín 1
Milan 1
Munich 1
Norwalk 1
Palermo 1
Paris 1
Portland 1
Pozzuoli 1
Richmond 1
Rochester 1
Seoul 1
Sousse 1
São Paulo 1
Tokyo 1
Trieste 1
Verona 1
Wigan 1
Wuhan 1
Yuseong-gu 1
Totale 603
Nome #
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 401
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 159
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas 104
Wild-type idh enzymes as actionable targets for cancer therapy 76
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells 27
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer 17
Biomimetic mesoporous vectors enabling the efficient inhibition of wild-type isocitrate dehydrogenase in multiple myeloma cells 10
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma 8
Totale 802
Categoria #
all - tutte 2.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.152


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020104 0 0 0 0 8 12 25 14 14 14 7 10
2020/2021166 13 18 7 5 22 15 11 11 14 22 15 13
2021/2022115 4 12 14 8 4 3 7 3 13 14 20 13
2022/2023155 16 22 4 17 11 32 4 7 19 7 12 4
2023/202488 6 10 6 2 3 12 5 14 0 10 12 8
2024/202564 6 24 7 23 4 0 0 0 0 0 0 0
Totale 802